Shares of Universe Pharmaceuticals INC (NYSE:UPC – Get Free Report) rose 0.5% on Tuesday . The stock traded as high as $3.97 and last traded at $3.97. Approximately 26,211 shares were traded during trading, a decline of 85% from the average daily volume of 175,066 shares. The stock had previously closed at $3.95.
Universe Pharmaceuticals Trading Up 0.5%
The firm has a 50-day moving average price of $4.46 and a two-hundred day moving average price of $13.32.
Institutional Trading of Universe Pharmaceuticals
A hedge fund recently bought a new stake in Universe Pharmaceuticals stock. Anson Funds Management LP bought a new position in shares of Universe Pharmaceuticals INC (NYSE:UPC – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 230,407 shares of the company’s stock, valued at approximately $141,000. Anson Funds Management LP owned 13.40% of Universe Pharmaceuticals at the end of the most recent quarter. Institutional investors own 0.18% of the company’s stock.
About Universe Pharmaceuticals
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.
Recommended Stories
- Five stocks we like better than Universe Pharmaceuticals
- How to Invest in Blue Chip Stocks
- Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
- What Are Growth Stocks and Investing in Them
- U.S. Steel Stock Burns the Bears With Surprise Upside Move
- When to Sell a Stock for Profit or Loss
- Lululemon, UNH, Enphase: Bad News, Good Opportunity?
Receive News & Ratings for Universe Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universe Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.